Hence, we conclude that R5 HIV-1 variants with increased sensitivity to TriMAb neutralization may emerge during severe immunodeficiency and display augmented infectivity, in addition to Env with reduced glycosylation and an increase in net positive charge. This evidence concerns the gene ERVW-1 and immunodeficiency disease.